Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2023 (1)
  • 2022 (1)
  • 2021 (5)

Subject

  • Prescription Drugs (4)
  • Diversion Division (2)
  • Drug Trafficking (2)
  • Pharmaceuticals/Pharmacists/Physicians (2)
  • Arrests/Convictions - Major (1)
  • Guilty Plea (1)
  • Overdose (1)
  • Prevention/Education - DEA websites GSAD, JTT etc (1)

Drug Name

  • Fentanyl (89)
  • Cocaine (78)
  • Heroin (67)
  • Methamphetamine (52)
  • Oxycodone (11)
  • Marijuana (Cannabis) (7)
  • Synthetic Opioids (4)
  • Steroids (3)
  • Ecstasy/MDMA (2)
  • Amphetamines (1)
  • Hydromorphone (1)
  • Morphine (1)
  • Opioids (7)

Field Division

  • Washington, DC (55)
  • Miami (9)
  • Seattle (8)
  • Atlanta (7)
  • San Francisco (6)
  • New England (5)
  • Sede (5)
  • Chicago (4)
  • Houston (4)
  • New York (3)
  • St. Louis (3)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
  • Dallas (5)
  • New Jersey (2)
Clear All Results
PRESS RELEASE

Denton Physician Sentenced for Over-Prescribing Opioids

Mayo 19, 2023
DALLAS, TX – A Denton physician has been sentenced to federal prison for drug trafficking violations announced Special Agent in Charge of the DEA Dallas Eduardo A. Chávez today. Stanley Charles Evans, 63, pleaded guilty on Sep. 12, 2022, to conspiracy to distribute and dispense controlled substances and health care...
Mayo 19, 2023
PRESS RELEASE

Arlington Doctor Sentenced to 12 Years in Pill Mill Case

Marzo 25, 2022
DALLAS, TX- An Arlington physician has been sentenced to 12 years in federal prison for fraud and drug crimes, announced DEA Special Agent in Charge Eduardo A. Chávez. In July 2021, a federal jury convicted physician Clinton Battle, 69, of one count of conspiracy to distribute controlled substances and one...
Marzo 25, 2022
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Noviembre 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
Noviembre 30, 2021
PRESS RELEASE

DEA Issues Public Safety Alert on Sharp Increase in Fake Prescription Pills Containing Fentanyl and Meth

Septiembre 27, 2021
Newark, N.J. – Today, the Drug Enforcement Administration issued a Public Safety Alert warning Americans of the alarming increase in the lethality and availability of fake prescription pills containing fentanyl and methamphetamine. DEA’s Public Safety Alert, the first in six years, seeks to raise public awareness of a significant nationwide...
Septiembre 27, 2021
PRESS RELEASE

Arlington Doctor and Nurse Practitioner Found Guilty of Operating a Pill Mill

Julio 07, 2021
DALLAS - An Arlington physician has been convicted of drug crimes, announced today by DEA Dallas Special Agent in Charge Eduardo A. Chávez Following five days of trial, a federal jury convicted physician Clinton Battle, 68, of one count of conspiracy to distribute controlled substances and one count of distribution...
Julio 07, 2021
PRESS RELEASE

Doctor Convicted of Second Degree Murder

Abril 30, 2021
OKLAHOMA CITY - On April 30, 2021, a state jury in Oklahoma City, Oklahoma convicted Dr. Regan Nichols of one count of second degree murder in relation to the death of one of her patients. Nichols was originally charged with five counts of second degree murder in relation to the...
Abril 30, 2021
PRESS RELEASE

Chinese national sentenced to 28 months in prison for importing fentanyl analogues and money laundering

Enero 13, 2021
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Susan A. Gibson, and acting U.S. Attorney for the District of New Jersey, Rachael A. Honig, announced a Chinese national who held high-level executive positions at chemical and pharmaceutical companies in China was sentenced today...
Enero 13, 2021
Showing 1 - 7 of 7 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster